Ashkan Bigham
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ashkan Bigham has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
- Mohammad Rafienia
Biosensor Research Center (BRC), Isfahan University of Medical Sciences (IUMS), Isfahan, Iran
6 shared publications - Mohamadreza Shakiba
Department of Chemistry, Amirkabir University of Technology, Tehran, Iran
4 shared publications S.A. Hassanzadeh-Tabrizi
4 shared publications- Sayed Ali Hassanzadeh Tabrizi
Department of Materials Engineering, Na.C., Islamic Azad University, Najafabad, Iran
4 shared publications Luigi Ambrosio
Institute of Polymers, Composites and Biomaterials, National Research Council of Italy (IPCB-CNR), Viale John Fitzgerald Kennedy 54, Mostra d'Oltremare Padiglione 20, 80125, Naples, Italy
3 shared publications- Majid Abdouss
Department of Chemistry, Amirkabir University of Technology, Tehran, Iran
3 shared publications
Latest Publications
- 6 April 2026
- Published by Elsevier in Biomaterials
- Vol. 333, 124200
Zinc-containing biomaterials for bone disease therapy and tissue repair: Design principles, mechanistic insights, and translational pathways
- 6 April 2026
- Published by Elsevier in Biomaterials
- Vol. 333, 124200
Zinc-containing biomaterials for bone disease therapy and tissue repair: Design principles, mechanistic insights, and translational pathways
- Open Access
- 1 April 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 58, 422-471
Black phosphorus in theragenerative medicine: a multi-organ perspective on disease modulation and tissue repair
Black phosphorus (BP) has attracted considerable attention as a biodegradable, stimuli-responsive 2D nanomaterial, emerging as a powerful theragenerative platform that integrates disease modulation with tissue regeneration. While earlier studies focused mainly on its anticancer properties, this review provides the first comprehensive analysis of BP as a theragenerative agent, unifying its disease-modulating capacity with its ability to stimulate tissue regeneration across multiple organs. BP exhibits several shared advantages: its degradation releases bioactive phosphate ions that support tissue repair; its highly reactive surface promotes cell interactions and enables efficient drug loading and delivery; its responsiveness to external stimuli, such as Near-infrared (NIR) light, ultrasound, and electrical signals, allows precise, on-demand therapeutic activation; and its ability to modulate reactive oxygen species (ROS) and immune modulation helps balance inflammation and regeneration. These properties collectively enhance osteogenesis and implant integration in bone, accelerate wound healing in skin, promote neural repair and redox homeostasis, protect cardiac tissue, and support recovery in kidney and liver injuries. By highlighting these mechanisms, this review emphasizes BP's versatility as a multifunctional nanomaterial capable of addressing pathological conditions while simultaneously stimulating endogenous regenerative pathways, thereby laying the foundation for its translation into next-generation theragenerative platforms.
- 1 April 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 58, 422-471
Open AccessBlack phosphorus in theragenerative medicine: a multi-organ perspective on disease modulation and tissue repair
Black phosphorus (BP) has attracted considerable attention as a biodegradable, stimuli-responsive 2D nanomaterial, emerging as a powerful theragenerative platform that integrates disease modulation with tissue regeneration. While earlier studies focused mainly on its anticancer properties, this review provides the first comprehensive analysis of BP as a theragenerative agent, unifying its disease-modulating capacity with its ability to stimulate tissue regeneration across multiple organs. BP exhibits several shared advantages: its degradation releases bioactive phosphate ions that support tissue repair; its highly reactive surface promotes cell interactions and enables efficient drug loading and delivery; its responsiveness to external stimuli, such as Near-infrared (NIR) light, ultrasound, and electrical signals, allows precise, on-demand therapeutic activation; and its ability to modulate reactive oxygen species (ROS) and immune modulation helps balance inflammation and regeneration. These properties collectively enhance osteogenesis and implant integration in bone, accelerate wound healing in skin, promote neural repair and redox homeostasis, protect cardiac tissue, and support recovery in kidney and liver injuries. By highlighting these mechanisms, this review emphasizes BP's versatility as a multifunctional nanomaterial capable of addressing pathological conditions while simultaneously stimulating endogenous regenerative pathways, thereby laying the foundation for its translation into next-generation theragenerative platforms.
- 12 November 2025
- Published by Elsevier in Ceramics International
- Vol. 51 (30) , 63160-63170
Fabrication and characterization of 3D porous microtube Bioglass 58S using a sacrificial Polyethersulfone template for bone tissue engineering
- 12 November 2025
- Published by Elsevier in Ceramics International
- Vol. 51 (30) , 63160-63170
Fabrication and characterization of 3D porous microtube Bioglass 58S using a sacrificial Polyethersulfone template for bone tissue engineering
- 29 September 2025
- Published by British Editorial Society of Bone & Joint Surgery in Orthopaedic Proceedings
- Vol. 107-B (SUPP_8) , 1
A MULTIFUNCTIONAL 3D-PRINTED SCAFFOLD WITH THERAPEUTIC AND REGENERATIVE POTENTIAL FOR BONE CANCER THERAPY AND TISSUE REGENERATION
Malignant bone tumors pose clinical challenges, requiring both tumor removal and subsequent bone regeneration [1]. This necessitates advanced biomaterials designed through interdisciplinary strategies capable of both therapeutic and regenerative functions—a concept known as “theragenerative” biomaterials [2–4].This study presents a novel multifunctional 3D-printed scaffold composed of Sphene (CaTiSiO5) for bone cancer therapy and tissue regeneration Sphene nanoparticles were synthesized followed by fabrication of 3D printed scaffolds. The scaffolds were coated with mesoporous bioactive glass (MBG) to enhance bioactivity and a nanocomposite of black phosphorus (BP) and polydopamine (PD) to provide anticancer functionality and immunomodulatory effects. Study objectives included: (I) Fabrication of 3D-printed Sphene scaffolds, (II) MBG coating to improve bioactivity, (III) BP-PD deposition to confer anticancer activity, (IV) In vitro assessment of therapeutic and regenerative potential.Thermal optimization during sintering revealed 1300°C as the optimal temperature, preserving scaffold integrity. Via an innovative sol-gel technique, MBG was formed uniformly on the scaffolds and then, the BP-PD deposition was confirmed. Scaffolds exhibited bioactivity in simulated body fluid. Mesenchymal stem cell assays demonstrated excellent cytocompatibility, and the surface-modified scaffolds stimulated the proliferation, adhesion, and osteogenic differentiation of the cells. Anticancer studies using SAOS-2 osteosarcoma cells revealed significant tumor suppression, further enhanced by near-infrared (NIR) laser irradiation. BP-PD-coated scaffolds selectively inhibited osteosarcoma cells while supporting healthy cell growth.Preliminary findings suggest that BP specifically targets cancer cells while the surface coatings improve bioactivity kinetics. The scaffolds also promoted osteogenesis, as evidenced by early and late osteogenic protein expression.This study introduces a novel theragenerative scaffold combining Sphene, MBG, and BP-PD, offering dual-functionality for bone cancer therapy and tissue regeneration. Ongoing investigations aim to further elucidate its physicochemical and biological properties.Supported by the Joint CNR-MOST (China) Collaboration Project 2024–2025 (CUP B63C24000210005) and by the National Key Research and Development Program of China (2023YFE0126900).
- 29 September 2025
- Published by British Editorial Society of Bone & Joint Surgery in Orthopaedic Proceedings
- Vol. 107-B (SUPP_8) , 1
A MULTIFUNCTIONAL 3D-PRINTED SCAFFOLD WITH THERAPEUTIC AND REGENERATIVE POTENTIAL FOR BONE CANCER THERAPY AND TISSUE REGENERATION
Malignant bone tumors pose clinical challenges, requiring both tumor removal and subsequent bone regeneration [1]. This necessitates advanced biomaterials designed through interdisciplinary strategies capable of both therapeutic and regenerative functions—a concept known as “theragenerative” biomaterials [2–4].This study presents a novel multifunctional 3D-printed scaffold composed of Sphene (CaTiSiO5) for bone cancer therapy and tissue regeneration Sphene nanoparticles were synthesized followed by fabrication of 3D printed scaffolds. The scaffolds were coated with mesoporous bioactive glass (MBG) to enhance bioactivity and a nanocomposite of black phosphorus (BP) and polydopamine (PD) to provide anticancer functionality and immunomodulatory effects. Study objectives included: (I) Fabrication of 3D-printed Sphene scaffolds, (II) MBG coating to improve bioactivity, (III) BP-PD deposition to confer anticancer activity, (IV) In vitro assessment of therapeutic and regenerative potential.Thermal optimization during sintering revealed 1300°C as the optimal temperature, preserving scaffold integrity. Via an innovative sol-gel technique, MBG was formed uniformly on the scaffolds and then, the BP-PD deposition was confirmed. Scaffolds exhibited bioactivity in simulated body fluid. Mesenchymal stem cell assays demonstrated excellent cytocompatibility, and the surface-modified scaffolds stimulated the proliferation, adhesion, and osteogenic differentiation of the cells. Anticancer studies using SAOS-2 osteosarcoma cells revealed significant tumor suppression, further enhanced by near-infrared (NIR) laser irradiation. BP-PD-coated scaffolds selectively inhibited osteosarcoma cells while supporting healthy cell growth.Preliminary findings suggest that BP specifically targets cancer cells while the surface coatings improve bioactivity kinetics. The scaffolds also promoted osteogenesis, as evidenced by early and late osteogenic protein expression.This study introduces a novel theragenerative scaffold combining Sphene, MBG, and BP-PD, offering dual-functionality for bone cancer therapy and tissue regeneration. Ongoing investigations aim to further elucidate its physicochemical and biological properties.Supported by the Joint CNR-MOST (China) Collaboration Project 2024–2025 (CUP B63C24000210005) and by the National Key Research and Development Program of China (2023YFE0126900).
- 9 June 2025
- Published by Wiley in Archiv der Pharmazie
- Vol. 358 (6) , e70013
The Therapeutic Potential of Berberine in Lung Cancer
Lung cancer has the second‐highest incidence rate after breast cancer and remains the leading cause of cancer‐related mortality. The 1‐year survival rate for lung cancer patients is below 50%, highlighting the urgent need for novel therapeutic strategies and drug development. Phytochemicals and their derivatives have been widely explored for their anticancer properties, serving as chemotherapeutic agents against various types of cancer. One of these herbal compounds, berberine (BBR), a quaternary isoquinoline alkaloid, has shown significant promise in preclinical studies and is currently undergoing clinical trials for cancer treatment. BBR exhibits diverse biological activities, contributing to its anticancer potential, including antioxidant, antidiarrheal, antidiabetic, antimicrobial, and so on. However, despite its multifunctional therapeutic potential, BBR faces several limitations, hindering its clinical application, like poor bioavailability, low tissue uptake, a short plasma half‐life, and rapid metabolic elimination. To address these challenges, various targeted drug delivery approaches have been developed to improve its efficacy. This review aims to provide a comprehensive overview of drug delivery strategies designed to encapsulate BBR for enhanced lung cancer therapy, highlighting the most recent advancements in the field. Moreover, the molecular structure of BBR and the biological pathways it targets to inhibit lung cancer progression are discussed in detail. Finally, BBR‐encapsulated nanocarriers specifically developed for lung cancer therapy are evaluated in terms of their benefits, limitations, and overall therapeutic potential.
- 9 June 2025
- Published by Wiley in Archiv der Pharmazie
- Vol. 358 (6) , e70013
The Therapeutic Potential of Berberine in Lung Cancer
Lung cancer has the second‐highest incidence rate after breast cancer and remains the leading cause of cancer‐related mortality. The 1‐year survival rate for lung cancer patients is below 50%, highlighting the urgent need for novel therapeutic strategies and drug development. Phytochemicals and their derivatives have been widely explored for their anticancer properties, serving as chemotherapeutic agents against various types of cancer. One of these herbal compounds, berberine (BBR), a quaternary isoquinoline alkaloid, has shown significant promise in preclinical studies and is currently undergoing clinical trials for cancer treatment. BBR exhibits diverse biological activities, contributing to its anticancer potential, including antioxidant, antidiarrheal, antidiabetic, antimicrobial, and so on. However, despite its multifunctional therapeutic potential, BBR faces several limitations, hindering its clinical application, like poor bioavailability, low tissue uptake, a short plasma half‐life, and rapid metabolic elimination. To address these challenges, various targeted drug delivery approaches have been developed to improve its efficacy. This review aims to provide a comprehensive overview of drug delivery strategies designed to encapsulate BBR for enhanced lung cancer therapy, highlighting the most recent advancements in the field. Moreover, the molecular structure of BBR and the biological pathways it targets to inhibit lung cancer progression are discussed in detail. Finally, BBR‐encapsulated nanocarriers specifically developed for lung cancer therapy are evaluated in terms of their benefits, limitations, and overall therapeutic potential.
- 30 March 2025
- Published by Elsevier in Environmental Research
- Vol. 276, 121403
Advanced nanofibers for water treatment: Unveiling the potential of electrospun polyacrylonitrile membranes
- 30 March 2025
- Published by Elsevier in Environmental Research
- Vol. 276, 121403
Advanced nanofibers for water treatment: Unveiling the potential of electrospun polyacrylonitrile membranes
- Open Access
- 2 December 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 54 (2) , 827-897
Black phosphorus-based nanoplatforms for cancer therapy: chemistry, design, biological and therapeutic behaviors
Black phosphorus nanomaterials have opened new doors to cancer therapy. They can induce anticancer activities intrinsically (selectively) and/or with external stimuli (PTT, PDT, SDT, etc. ) and are highly suitable for drug/gene delivery.
- 2 December 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 54 (2) , 827-897
Open AccessBlack phosphorus-based nanoplatforms for cancer therapy: chemistry, design, biological and therapeutic behaviors
Black phosphorus nanomaterials have opened new doors to cancer therapy. They can induce anticancer activities intrinsically (selectively) and/or with external stimuli (PTT, PDT, SDT, etc. ) and are highly suitable for drug/gene delivery.
- 22 November 2024
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 13 (2) , 379-407
Microneedle patches: a new vantage point for diabetic wound treatments
Recent advancements pertaining to the application of microneedle patches for diabetic wound treatment are reviewed, focusing on challenges and future perspectives.
- 22 November 2024
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 13 (2) , 379-407
Microneedle patches: a new vantage point for diabetic wound treatments
Recent advancements pertaining to the application of microneedle patches for diabetic wound treatment are reviewed, focusing on challenges and future perspectives.
- Open Access
- 31 August 2024
- Published by Royal Society of Chemistry (RSC) in Materials Horizons
- Vol. 11 (24) , 6257-6288
3D and 4D printing of MXene-based composites: from fundamentals to emerging applications
Extracellular vesicles (EVs) have excellent biocompatibility and long retention times in the circulation and have consequently been expected to be useful as drug-delivery systems. However, their applications have been limited because of the inability to introduce hydrophobic compounds to EVs without the use of harmful organic solvents. Herein, we developed an organic-solvent-free drug-loading technique based on the host exchange reaction. We demonstrated that the exchange reaction enabled quantitative loading of EVs with highly concentrated (0.1 mM) hydrophobic fullerene derivatives. Fullerene derivative–loaded EVs (EVs/C60) could eliminate cancer cell lines more efficiently than fullerene derivative-loaded liposomes (Lip/C60). Moreover, the photodynamic activity of EVs/C60 was fivefold higher than that of the clinically available photosensitizer photofrin. EVs/C60 could efficiently suppress tumor growth in tumor-xenograft model mice.
- 31 August 2024
- Published by Royal Society of Chemistry (RSC) in Materials Horizons
- Vol. 11 (24) , 6257-6288
Open Access3D and 4D printing of MXene-based composites: from fundamentals to emerging applications
Extracellular vesicles (EVs) have excellent biocompatibility and long retention times in the circulation and have consequently been expected to be useful as drug-delivery systems. However, their applications have been limited because of the inability to introduce hydrophobic compounds to EVs without the use of harmful organic solvents. Herein, we developed an organic-solvent-free drug-loading technique based on the host exchange reaction. We demonstrated that the exchange reaction enabled quantitative loading of EVs with highly concentrated (0.1 mM) hydrophobic fullerene derivatives. Fullerene derivative–loaded EVs (EVs/C60) could eliminate cancer cell lines more efficiently than fullerene derivative-loaded liposomes (Lip/C60). Moreover, the photodynamic activity of EVs/C60 was fivefold higher than that of the clinically available photosensitizer photofrin. EVs/C60 could efficiently suppress tumor growth in tumor-xenograft model mice.